Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,165 | -146,412 | -137,467 | -80,348 | -45,621 |
| Depreciation Amortization | 8,655 | 28,821 | 20,901 | 13,665 | 6,605 |
| Accounts receivable | N/A | N/A | -15,957 | N/A | N/A |
| Accounts payable and accrued liabilities | -9,406 | 3,457 | -2,286 | -7,356 | -3,409 |
| Other Working Capital | -13,403 | -70,694 | -24,475 | -6,338 | 10,463 |
| Other Operating Activity | 23,796 | 53,533 | 62,732 | 36,419 | 20,408 |
| Operating Cash Flow | $-33,523 | $-131,295 | $-96,552 | $-43,958 | $-11,554 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -22,506 | 103,296 | 54,946 | 7,460 | 25,037 |
| PPE Investments | -3,831 | -42,772 | -32,929 | -24,001 | -10,636 |
| Net Acquisitions | N/A | 30,113 | N/A | N/A | N/A |
| Purchase Of Investment | -105 | -24,230 | -16,771 | -13,783 | -7,484 |
| Other Investing Activity | 1,361 | 21,343 | 7,366 | 6,448 | 1,018 |
| Investing Cash Flow | $-25,081 | $87,750 | $12,612 | $-23,876 | $7,935 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,192 | 29,731 | N/A | 11,653 | 5,970 |
| Common Stock Issued | N/A | N/A | 19,207 | N/A | N/A |
| Other Financing Activity | 0 | -15,649 | -9,240 | -9,058 | 0 |
| Financing Cash Flow | $7,192 | $14,082 | $9,967 | $2,595 | $5,970 |
| Exchange Rate Effect | -38 | 1,097 | 807 | 1,351 | 590 |
| Beginning Cash Position | 155,249 | 183,615 | 183,615 | 183,615 | 183,615 |
| End Cash Position | 103,799 | 155,249 | 110,449 | 119,727 | 186,556 |
| Net Cash Flow | $-51,450 | $-28,366 | $-73,166 | $-63,888 | $2,941 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,523 | -131,295 | -96,552 | -43,958 | -11,554 |
| Capital Expenditure | -3,831 | -42,772 | -32,929 | -24,001 | -10,636 |
| Free Cash Flow | -37,354 | -174,067 | -129,481 | -67,959 | -22,190 |